Skip to content

The efficacy of repetitive transcranial magnetic stimulation over the several sites of brain in treatment of Parkinsonism.

The efficacy of repetitive transcranial magnetic stimulation over the several sites of brain in treatment of Parkinsonism. - The efficacy of repetitive transcranial magnetic stimulation over the several sites of brain in treatment of Parkinsonism.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010523
Enrollment
20
Registered
2013-04-17
Start date
2013-04-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinsonism

Interventions

Repetitive transcranial magnetic stimulation over the primary motor area Repetitive transcranial magnetic stimulation over the supplementary motor area Repetitive transcranial magnetic stimulation ove

Sponsors

Osaka University, Department of Neuromodulation and Neurosurgery,Office forUniversity-Industry Collaboration
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnosed as Parkinsonism (2)Patients who consented to keep drug and living conditions during the study (3) No cognitive disorders, aphasia, psychiatric disorder, higher brain dysfunction (4) the patients who can write questionare (5) over 20 years old (6) Those who give us informed consent to participate in the present study after detailed explanation of the study

Exclusion criteria

Exclusion criteria: (1) No implantation of metal in head, except in the mouth (2) Those having heart pacemaker or drug infusion pomp (3) Those having heart pacemaker or severe heart diseases (4) Those having the deep brain stimulation or the spinal cord stimulation (5)Major cerebral infarction, head traum, epilepsy, brain tumor (6) Pregnant or intend to be pregnant (7) the patients who are excluded by doctors

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale(UPDRS),Parkinson's Disease Questionnaire-39(PDQ-39)

Secondary

MeasureTime frame
5-point scale for daily life and tremor, Apathy scale,Montogomery and Asberg depression rating scale,Self-rating Depression Scale(SDS),analyzed parameters of finger tapping by magnetic sensor,Timed up and go test

Countries

Japan

Contacts

Public ContactMasaru Yokoe

Osaka university Department of Neuromodulation and Neurosurgery,Office forUniversity-Industry Collaboration

myokoe@neurol.med.osaka-u.ac.jp+81-6-6879-3571

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026